Kirpekar Sahil
SEC insider (Form 3/4/5 filer). CIK 0001951712. Chief Business Officer at ATAI Life Sciences N.V. (ATAI). 2 reported Form 4/5 transactions since Sep 2024; latest on Mar 21, 2025. Located in BERLIN, 2M.
Companies Kirpekar Sahil has filed insider reports for
- ATAI Life Sciences N.V. (ATAI): Officer, Chief Business Officer
Kirpekar Sahil
CIK: 0001951712
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (50.0%)
Position reduction
Option Exercises (M)1 (50.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATAI
ATAI Life Sciences N.V.
Officer